NASDAQ, GILD - Gilead Sciences Inc
Gilead Sciences, Inc. (Gilead, we, us or our), incorporated in Delaware on
June 22, 1987, is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. Our
mission is to advance the care of patients suffering from life-threatening
diseases worldwide. Headquartered in Foster City, California, we have operations
in North America, Europe and Australia. To date, we have focused our efforts on
bringing novel therapeutics for the treatment of life-threatening diseases to
market. We continue to seek to add to our existing portfolio of products through
our internal discovery and clinical development programs and through an active
product acquisition and in-licensing strategy. ...
Read SEC Filing on NASDAQ.com »